Allstate Corp Bio Rad Laboratories, Inc. Transaction History

Allstate Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $8,664 - $11,828	-21 Reduced 1.57%	1,314 $548,000
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $509,109 - $655,681	-1,098 Reduced 45.13%	1,335 $661,000
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $865,540 - $1.21 Million	-1,650 Reduced 40.41%	2,433 $1.37 Million
Q4 2021 Feb 15, 2022	BUY	$708.84 - $794.68 $2.89 Million - $3.24 Million	4,083 New	4,083 $3.09 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.38B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.